Anti hypertensive medications and blood sugar: Theories and implications

被引:27
作者
Blackburn, DF
Wilson, TW
机构
[1] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK S7N 5C9, Canada
[2] Univ Saskatchewan, Coll Med, Saskatoon, SK S7N 5C9, Canada
关键词
diabetes mellitus; hypertension;
D O I
10.1016/S0828-282X(06)70902-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Increased rates (if diabetes have been reported with thiazide diuretics and beta-blockers, but not with angiotensin-converting enzyme inhibitors, angiotensin receptor blockers or calcium channel blockers. These observations are important because significant glycemic effects of drugsmay be a source of accelerated cardiovascular risk that is not detectable during restricted clinical trial follow-up periods. The extent to Which diabetes is affected by these medications remains unclear, as is the precise mechanism by which diabetes is promoted. However, several plausible theories are presented herein. Although drug-induced diabetes has been a concern for several years, not enough is information is available to influence prescribing for the majority of patients. The number one priority should be controlling blood pressure in a timely manner.
引用
收藏
页码:229 / 233
页数:5
相关论文
共 52 条
[21]   Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors:: the CHARM-Alternative trial [J].
Granger, CB ;
McMurray, JJV ;
Yusuf, S ;
Held, P ;
Michelson, EL ;
Olofsson, B ;
Östergren, J ;
Pfeffer, MA ;
Swedberg, K .
LANCET, 2003, 362 (9386) :772-776
[22]   Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus [J].
Gress, TW ;
Nieto, FJ ;
Shahar, E ;
Wofford, MR ;
Brancati, FL .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (13) :905-912
[23]   TREATMENT WITH A BETA-BLOCKER WITH BETA(2)-AGONISM IMPROVES GLUCOSE AND LIPID-METABOLISM IN ESSENTIAL-HYPERTENSION [J].
HAENNI, A ;
LITHELL, H .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1994, 43 (04) :455-461
[24]   Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension:: the Captopril Prevention Project (CAPPP) randomised trial [J].
Hansson, L ;
Lindholm, LH ;
Niskanen, L ;
Lanke, J ;
Hedner, T ;
Niklason, A ;
Luomanmäki, K ;
Dahlöf, B ;
de Faire, U ;
Mörlin, C ;
Karlberg, BE ;
Wester, PO ;
Björck, JE .
LANCET, 1999, 353 (9153) :611-616
[25]   EFFECTS OF LOW-DOSE VERSUS CONVENTIONAL-DOSE THIAZIDE DIURETIC ON INSULIN ACTION IN ESSENTIAL-HYPERTENSION [J].
HARPER, R ;
ENNIS, CN ;
SHERIDAN, B ;
ATKINSON, AB ;
JOHNSTON, GD ;
BELL, PM .
BRITISH MEDICAL JOURNAL, 1994, 309 (6949) :226-230
[26]   SERUM GLUCOSE-LEVELS DURING LONG-TERM OBSERVATION OF TREATED AND UNTREATED MEN WITH MILD HYPERTENSION - THE OSLO STUDY [J].
HELGELAND, A ;
LEREN, P ;
FOSS, OP ;
HJERMANN, I ;
HOLME, I ;
LUNDLARSEN, PG .
AMERICAN JOURNAL OF MEDICINE, 1984, 76 (05) :802-805
[27]   Effects of combination therapy with an angiotensin converting enzyme inhibitor and thiazide diuretic on insulin action in essential hypertension [J].
Hunter, SJ ;
Harper, R ;
Ennis, CN ;
Crothers, E ;
Sheridan, B ;
Johnston, GD ;
Atkinson, AB ;
Bell, PM .
JOURNAL OF HYPERTENSION, 1998, 16 (01) :103-109
[28]  
Jacob S, 1996, J HYPERTENS, V14, P489
[29]   Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial [J].
Julius, S ;
Kjeldsen, SE ;
Weber, M ;
Brunner, HR ;
Ekman, S ;
Hansson, L ;
Hua, TS ;
Laragh, J ;
McInnes, GT ;
Mitchell, L ;
Plat, F ;
Schork, A ;
Smith, B ;
Zanchetti, A .
LANCET, 2004, 363 (9426) :2022-2031
[30]  
Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512